Realta Investment Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Realta Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,002	Closed	-$41K	–	1270
2019 Q4	$41K	Buy	4,002 +1,900	+90%	+$17K	0.01%	722
2019 Q3	$14K	Sell	2,102 -253	-11%	-$1.94K	﹤0.01%	1029
2019 Q2	$22K	Buy	2,355 +53	+2%	+$639	0.01%	907
2019 Q1	$37K	Buy	+2,302	New	+$40.6K	0.02%	625

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Realta Investment Advisors's TEVA Position: Q1 2020 in Review

Realta Investment Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2020, closing a stake of 4,002 shares — an estimated $41K sold.

Realta Investment Advisors first reported a position in TEVA in Q1 2019 and held it in 4 quarters. The position peaked at $41K in Q4 2019. 459 funds tracked by Wall St. Rank hold TEVA as of Q1 2020.

Realta Investment Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2020 after selling out during the quarter.
Realta Investment Advisors sold 4,002 Teva Pharmaceutical Industries Limited shares in Q1 2020, an estimated $41K.
Realta Investment Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q1 2019 and held it in 4 quarters.
Realta Investment Advisors's Teva Pharmaceutical Industries Limited position peaked at $41K in Q4 2019.
459 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2020.

Based on Realta Investment Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.